Ftse Mib
33.609,85
-2,18%
DAX
18.265,68
-2,03%
S&P 500
5.433,74
0,23%
NASDAQ
17.667,56
0,34%
Bitcoin
66.756,13
-2,19%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Provention Bio Inc (PRVB) Provention Bio Inc (PRVB) Notizie

PRVB

Provention Bio (PRVB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRVB
DataOraFonteTitoloSimboloCompagnia
08/05/202322:18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PRVBProvention Bio Inc
01/05/202312:20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVBProvention Bio Inc
28/04/202322:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVBProvention Bio Inc
28/04/202300:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVBProvention Bio Inc
27/04/202323:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVBProvention Bio Inc
27/04/202322:49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRVBProvention Bio Inc
27/04/202315:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVBProvention Bio Inc
27/04/202314:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PRVBProvention Bio Inc
19/04/202323:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVBProvention Bio Inc
29/03/202323:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRVBProvention Bio Inc
24/03/202312:53Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVBProvention Bio Inc
24/03/202312:11Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PRVBProvention Bio Inc
24/03/202311:05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PRVBProvention Bio Inc
17/03/202321:17Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRVBProvention Bio Inc
13/03/202321:39Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRVBProvention Bio Inc
13/03/202312:00PR Newswire (US)Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference CallNASDAQ:PRVBProvention Bio Inc
03/03/202322:05PR Newswire (US)Provention Bio Announces the Grant of Inducement AwardsNASDAQ:PRVBProvention Bio Inc
23/02/202314:30PR Newswire (US)Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023NASDAQ:PRVBProvention Bio Inc
13/02/202313:30PR Newswire (US)Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi USNASDAQ:PRVBProvention Bio Inc
08/02/202313:30PR Newswire (US)Provention Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:PRVBProvention Bio Inc
02/02/202322:01PR Newswire (US)Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®NASDAQ:PRVBProvention Bio Inc
05/01/202322:01PR Newswire (US)Provention Bio Announces Appointment of Rita Jain, M.D., to Board of DirectorsNASDAQ:PRVBProvention Bio Inc
21/11/202213:35TipRanksProvention Bio (PRVB) Receives a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
21/11/202205:15TipRanksSVB Securities Remains a Buy on Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202223:55TipRanksChardan Capital Sticks to Their Buy Rating for Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202211:09TipRanksProvention Bio (NASDAQ:PRVB) Stock Spikes as Diabetes Drug Gets FDA’s NodNASDAQ:PRVBProvention Bio Inc
18/11/202200:57Dow Jones NewsProvention Bio Up 8% on Diabetes Drug ApprovalNASDAQ:PRVBProvention Bio Inc
18/11/202200:39Dow Jones NewsProvention Bio Gets FDA OK for Diabetes DrugNASDAQ:PRVBProvention Bio Inc
17/11/202223:45PR Newswire (US)TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1DNASDAQ:PRVBProvention Bio Inc
07/11/202204:35TipRanksProvention Bio (PRVB) Gets a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRVB

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
BAMI
Banco BPM
BIT
IVG
Iveco Group NV
BIT
TEN
Tenaris
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network